Read, Watch or Listen

The FDA has approved a second generic version of mifepristone, a key medication for abortions in the U.S. The approval of Evita Solutions' generic drug follows a review of safety, though the FDA stated generic drug approval is largely mandated by law. This move, occurring just before a government shutdown, has drawn criticism from anti-abortion groups concerned about increased accessibility, while reproductive health advocates highlight the drug's long-standing safety and effectiveness.

Prepared by Lauren Mitchell and reviewed by editorial team.